deltatrials
Unknown PHASE2 INTERVENTIONAL 2-arm NCT04602715

The Safety, Efficacy, and Tolerability of Microbial Ecosystem Therapeutic-2 in People With Major Depression

Sponsor: NuBiyota

Conditions Anxiety Major Depressive Disorder
Interventions MET-2 Placebo
Updated 6 times since 2020 Last updated: May 9, 2021 Started: Apr 1, 2021 Primary completion: Jun 30, 2021 Completion: Jun 30, 2021
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Anxiety and Major Depressive Disorder, this trial is ongoing. The trial is conducted by NuBiyota and has accumulated 6 data snapshots since 2021. Psychiatric clinical trials are essential for establishing evidence-based treatment standards.

Status Flow

~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshotNot Yet Recruiting~Jan 2021 – ~Jun 2021 · 5 months · monthly snapshotNot Yet Recruiting~Jun 2021 – ~May 2023 · 23 months · monthly snapshotRecruiting~May 2023 – ~Jul 2024 · 14 months · monthly snapshotUnknown Status~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotUnknown~Sep 2024 – present · 22 months · monthly snapshotUnknown

Change History

6 versions recorded

  1. Sep 2024 — Present [monthly]

    Unknown PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Unknown PHASE2

    Status: Unknown Status → Unknown

  3. May 2023 — Jul 2024 [monthly]

    Unknown Status PHASE2

    Status: Recruiting → Unknown Status

  4. Jun 2021 — May 2023 [monthly]

    Recruiting PHASE2

    Status: Not Yet Recruiting → Recruiting

  5. Jan 2021 — Jun 2021 [monthly]

    Not Yet Recruiting PHASE2

▶ Show 1 earlier version

  1. Nov 2020 — Jan 2021 [monthly]

    Not Yet Recruiting PHASE2

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • NuBiyota
Data source: NuBiyota

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations